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Diagnosis and Treatment of Gonorrhea
Paul A. Kvale, M.D.*

The various methods for diagnosis of gonorrhea are reviewed. Gram-stained smear
of urethral exudate in the mate is appropriate, but for the female emphasis is
placed on the use of culture on Thayer-Martin
medium. Currently
effective
modalities of treatment are detailed, pointing out that higher doses of antibiotics
are generally required for females with pelvic inflammatory disease than for males
with acute gonococcal urethritis. The necessity for follow-up is also discussed.

two sexes that it should almost be considered two separate entities.
In the male, the traditional gramstained smear of urethral exudate is
adequate for diagnosis as it affords
98-99% accuracy.- In the early posttreatment assessment of cure, the gramstained smear is inadequate and cultures should be done. This is because
there may be a temporarily reduced
number of organisms in the discharge;
consequently, the organisms often cannot be seen. Later in the post-treatment
course, the organisms will multiply and
the quantity of exudate will usually
increase. Once again the smear becomes fairly reliable to assess the
results of treatment. If results are
doubtful or if exudate is present after
treatment, greater accuracy can be obtained with a culture.*
Svihus et al in 1961 suggested that
Mima polymorpha var. oxidans rather
than Af. gonorrhoeae was the causative
agent for "penicillin-resistant" acute
gonococcal urethritis in males.* This
is no longer thought to be true, and
most venereologists concur that the

In the year 1971 gonorrhea has
reached epidemic proportions. Nearly
500,000 cases were reported to the
Public Health Service in 1969 with an
estimated one mUlion additional cases
unreported during the same year.^ Since
then the incidence has continued to increase—a fact recognized by medical
personnel and widely reported in the
lay mass communications media.
It is incumbent upon physicians
dealing with gonorrhea to make an accurate diagnosis and to follow it with
treatment which will afford the best
possible chance of cure. The synopsis
presented here reviews some of the
latest methods avaflable for diagnosis
and treatment of gonorrhea in its most
common forms: acute urethritis in the
male, and acute or chronic pelvic inflammatory disease in the female. A
complete discussion of the complicated
forms of gonorrhea will not be attempted.
Diagnostic Methods
The disease is so different in the
* Department of Medicine
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gonococcus has gained relative, not absolute, resistance to penicUlin.^ '^
In the female with gonorrhea the
gram-stained smear of vaginal or cervical exudate is grossly unreliable. In
studies conducted in the Philippines
less than half of the readings were
correct with a gram-stained smear.*
Because of the volume of secretions
usually found in the vaginal vault and
cervical areas and the presence of many
different kinds of bacteria, there wiU
be false positive as well as false negative readings with the gram-stained
smear. Culture is the best means for
diagnosing gonorrhea in the female.

employed for maximum growth of N .
gonorrhoeae. Thayer-Martin medium
is an enriched chocolate agar to which
has been added a nutrient supplement
called Isovitalex** and the antibiotics
vancomycin, colistimethate and nystatin (VCN). Direct plating onto petri
dishes gives the optimum yield, but is
usually not practical in a hospital
setting. A suitable alternative is the
use of transport medium such as Ciflturettes. It has been shown that, with
infected patients actively shedding organisms, use of a transport medium
results in only a 5% loss in 12 hours,
17% loss m 24 hours, and 23% loss
in 48 hours.^^
Cultures are transferred to ThayerMartin medium and incubated in
candle jars under 10% carbon dioxide
tension. Typical gonococcal colonies
are picked after 24-48 hours of incubation and gram-stained for their morphological characteristics. Oxidase reactions will confirm the diagnosis and
sugar fermentations usually need not
be done. Except for the pathogenic
Neisseria, almost all organisms are inhibited by Thayer-Martin medium, including the saprophytic Neisseria.
Since 1959 fluorescent antibody
staining by delayed technique has also
been used to diagnose gonorrhea.* The
author believes it is no more accurate
than culture using the Thayer-Martin
medium; it is less accurate in assessing
cure, so it is seldom used.
Development of serologic techniques
for the diagnosis of gonorrhea is currently underway but not clinically
available at the present time. It shoifld
broaden the scope of diagnosis in the
future."

Two reports have confirmed that
cultures of the endocervix are the most
productive.''-^'' Nearly 50% of afl infected females will yield a positive culture from the anal canal. A small but
significant number (7%) have positive
cultures only in the anal c a n a l . T h e
vaginal vault and extemal os should
be wiped clean of debris with ring
forceps. A Culturette* cotton-tipped
applicator (or platinum wire loop,
when direct plating is done) shoifld be
inserted 1-2 cm into the endocervical
canal to obtain the specimen for culture. If a second site is to be cultured,
it should be the anus.
The time-in-cycle when cultures are
obtained is debated among venereologists. A previous study showed the
highest incidence of positive cultures
during the first five days of the cycle
(menses and immediately following),
and the lowest yield occurred during
mid-cycle (sixteenth through twentieth
days)."
Thayer-Martin medium is currently
'•Cuhurette: Medical Supply Company,
Rockford, Illinois.

**Isovitalex, Baltimore Biologic Laboratories.
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administration of readfly available
drugs by prostitutes and servicemen
overseas.*' Martin has shown what is
now widely appreciated as a nearly
universal relative resistance of the
gonococcus to peniciUin.^^ However,
penicfllin in adequate doses is still our
treatment of choice in 1971.

Treatment
Peniciflin is stiU the treatment of
choice for gonorrhea, but benzathine
peniciflin has no place in the modem
management of gonorrhea. The average in vitro sensitivity of stains isolated from treatment faflures has increased from 0.1 u/ml in 1954 to
0.5 u/ml in 1969. The minunal inhibitory concentration (MIC) of the
most resistant strains has shffted from
a high of 0.2 u/nfl to 3.5 u/ml in the
same period of time.^^ The incidence
of strains which require serum levels
of penicfllin greater than 0.5 u/ml has
increased to the point that adequate
serum levels cannot be achieved by
using benzathine penicfllin. Untfl recently the relatively resistant strains
were encoimtered mostly in the Pacific
and, to a lesser extent, on the West
Coast. Probably this was the resiflt of
suboptimal treatment and/or self-

MALES: (Table I) In a smafl pUot
study in the Pacific in 1966, Holmes
found that the Public Health Service
recommendations for using 2.4 mfllion
units of procaine peniciflin G resulted
in 28.6% failures. 1" An expanded
study showed that addition of probenecid to the 2.4 mfllion units of procaine
penicUhn G reduced the failure rate to
2.4% in a series of 391 men.^^ This
therapeutic program has been confirmed in a more recent study by Keys
in the same geographic area.^* For
males with acute gonococcal urethritis

TABLE I
TREATMENT FOR AAALES WITH ACUTE
GONOCOCCAL URETHRITIS
Procaine Penicillin G 2.4 x 10^ units IM + Probenecid 1.0 gm oral
"3-5 gm oral, or
Ampicillin

+ Probenecid 1.0 gm oral

_2.0gm IM

Tetracycline 1500 mg "load", then 500 mg q. i.d. x 4-7 days
Erythromycin 1500 mg "load", then 500 mg q. i.d. x 4-7 days
Cephaloridine 2.0 gm IM
Kanamycin 2.0 gm IM
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who have no history of hypersensitivity
to peniciflin, the administration of 1.0
gm probenecid orally either an hour
before or simultaneously with 2.4 million units aqueous procaine penicfllin
G I M is the current treatment of
choice.
Several alternative programs are
available. For instance, ampicillin has
simflar in-vitro inhibitory patterns to
benzyl peniciflin (G),^" and some of the
more resistant strains of N . gonorrhoeae are also more sensitive to ampicfllin than to benzyl penicfllin.^o
Several single dose ampicillin programs
have been reported recently.^^-^^-Each of the more successful programs
utflizes the drug probenecid to retard
the renal excretion of the ampiciflin.
Keys reported a 99% cure rate (105
of 106) using 2.0 ampicfllin I M with
probenecid. 18 Kvale noted that 3.5 gm
oral ampiciflin gave only 71.7% cures
when this drug was used alone. When
probenecid was added, the cure rate
was 96% (194 of 202).^! Nearly identical results were obtained by a Scandinavian group in 1969, employing a
simflar program of 2.0 gm oral ampiciflin with probenecid.2- On the other
hand, phenoxymethyl penicfllin—even
with probenecid—fafls to produce satisfactory cure rates and should not be
used for the treatment of gonorrhea.^^
For the patient who presents with a
history of hypersensitivity to penicfllin,
alternative drugs are available. A fouror seven-day program with an initial
"loading" dose of 1.5 gm oral tetracycline, followed by 500 mg q.i.d., was
98% effective in 530 men." This program is the treatment of choice for
both men and women who are hypersensitive to penicillin. Erythromycin in
the same doses will also produce a sat-

isfactory cure rate.-3 A single dose of
2.0 gm cephaloridine I M was 83.5%
effective in Keys' series.i'' In the same
report, Keys noted that a single I M
dose of 2.0 gm kanamycin was 93.4%
effective. Both cephaloridine and kanamycin should be used with caution
in patients who have any evidence of
renal insufficiency.
FEMALES: (Table II) In general,
the dose of antibiotics used must be
larger for females than for males. Anatomical differences allow sequestration of organisms and this is felt to be
responsible for the larger doses necessary to cure females. Lucas noted an
8.7% faflure rate in 1967 when he
used a single dose of 2.4 million units
of aqueous procaine penicillin G in a
series in the United States.-^ He reduced his faflure rate to 4% when the
dose was increased to 4.8 million units,
lohnson evaluated nine different programs in the Pacific in 1968.-" Several
regimens employed a combination of
crystalline and aqueous procaine peniciflin G in doses up to 6.0 miflion
units, and failure rates were stfll as
high as 13%. When probenecid was
added to the regimen using 6.0 mUlion
units of penicillin, the "cure" rate was
100%. Likewise, a 100% "cure" rate
was seen with an oral dose of 3.5 gm
ampicillin, either alone or with probenecid.2" It is probable that the cure
rates reported would have been lower
had the patients been followed for
longer than the seven days of hospitalization. However, it seems reasonable
to conclude that the large dose of
parenteral penicillin or oral ampicfllin
when used in combination with probenecid will be satisfactory for use in
females. Parenteral ampicfllin (2.0 or
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seven days with 500 mg tetracycline
q.i.d. This program should not be used
in the pregnant female during the latter
half of pregnancy because of the possibflity of staining the fetal teeth. In
such a case, erythromycin on an equal
gravimetric schedule is the preferred
antibiotic.

more grams) with probenecid can also
be used.
In the same series Johnson reported
several different single dose tetracycline regimens. Using 250 mg of oxytetracycline I M plus 1.0 gm of oral
tetracycline administered simultaneously, the cure rate was 85% (21 of 25).
The cure rate was increased somewhat
(94%, 33 of 35) when the dose was
increased to 500 mg of oxytetracycline
I M plus 1,500 mg of tetracycline
orally. No failures were seen in 11 patients treated with a single oral dose
of 2.5 gm tetracycline, but this dose
was poorly tolerated by patients (3 of
11 vomited). For the female who is
hypersensitive to penicfllin the most
practical approach for treatment is the
same program outlined for males: a
loading dose of 1.5 gm tetracycline is
given orally and is foflowed for four to

Follow Up
It is imperative in treating either
sex to assure adequate follow up. A
single post-treatment examination of
the male approximately one week later
is generally satisfactory. Ideally, the
patient should be seen in the morning,
prior to voiding, and examined for the
presence of urethral exudate or material which can be expressed after
prostatic massage. If any material is
obtained, this should be examined by
gram-stain and by culture. With the

TABLE II
TREATMENT FOR FEMALES* WITH PELVIC INFLAMMATORY DISEASE
(CHRONIC OR ACUTE)
Procaine Penicillin G 4.8 x 10^ units IM + Probenecid 1.0 gm oral
Ampicillin

3.5 gm oral, or
2.0 (or more) gm IM

+ Probenecid 1.0 gm oral

500 mg IM
Oxytetracycline

1500 mg oral

Simultaneous, single dose

Tetracycline 1500 mg "load", then 500 mg q.i.d. x 4-7 days
Erythromycin 1500 mg "load", then 500 mg q. i.d. x 4-7 days
* Note: Re-culture endocervix weekly x 4 after treatment.
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penicillin treatment programs described here, there wifl often be thin white
mucoid material (negative by culture
for A^. gonorrhoeae) which may or may
not be acompanied by irritative GU
symptoms. This syndrome, cafled
"postgonococcal urethritis" (PGU),^*
uncommonly foUows treatment with
broad spectrum antibiotics. If PGU is
asymptomatic, it generally requires no
treatment other than reassurance of the
patient and careful neglect. If symptoms are severe or discharge is copious,
satisfactory results can usuafly be
achieved by a four- to seven-day course
of tetracycline.
Follow up of the female who has
been treated for gonococcal pelvic inflammatory disease should include
examinations at weekly or biweekly
intervals for not less than one month.
Endocervical cultures should be obtained at each examination. A single
negative examination after treatment
does not assure treatment success.

In all cases of gonorrhea, serologic
examination for syphilis should be
done at the time of initial treatment
and monthly for three months after
treatment.
If doubt exists when the patient first
presents and the clinical suspicion is
high, it is far preferable to err on the
side of over-treatment than undertreatment. Any named contact or consort of a patient should likewise be
treated on epidemiologic grounds, regardless of culture results. This is particularly true for females. Simultaneous
treatment (or re-treatment) of husbandwife pairs should be practiced whenever this is possible.
Epidemiologic reporting of gonorrhea to public health officials is an
ideal method of management and
should be done in each case. Careful
attention to afl features of this disease
may help reverse the epidemic trends
we now see.

Generic And Trade Names Of Drugs

Ampicfllin—Amcill, Ampi-Co, Omnipen, Penbritin, Polycillin, Principen, Supen,
Totacillin; Benzathine penicfllin—BicilUn, Permapen;
Cephaloridine—Loridine;
Erythromycin—E-Mycin,
Erythrocin, Erythromycin, Ilosone; Kanamycin—Kantrex; Oxytetracycline—Oxy-Kesso-Tetra,
Terramycin; Penicfllin G procaine
(benzyl)—Crysticillin, Duracillin, Pentids-P, Wycillin; Phenoxymethyl penicfllin—
Betapen-VK, Compocillin-VK, Ledercillin-VK, V-Cillin-K, Veetids; Probenecid—
Benemid; and Tetracycline—Achromycin
V, Kesso-Tetra, Panmycin, Rexamycin,
Streclin, Sumycin, Tetrachel, Tetracyn.
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